查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2157179

生物可吸收藥物釋放型冠狀動脈支架系統市場：全球市場預測，2026-2032年

Bioabsorbable Eluting Coronary Stent System Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，生物可吸收藥物釋放型冠狀動脈支架系統的市場規模將成長至 29.8 億美元，複合年成長率為 11.58%。

主要市場統計數據
基準年 2025 13.8億美元
預計年份：2026年 15.4億美元
預測年份 2032 29.8億美元
複合年成長率 (%) 11.58%

生物可吸收藥物釋放型冠狀動脈支架系統：概述

生物可吸收藥物釋放型冠狀動脈支架系統結合了暫時的機械支撐、可控制的藥物釋放以及隨後的材料吸收。其臨床價值在於減少異物長期留置，同時在癒合期維持血管骨架的完整性。該系統的應用取決於證據品質、手術可靠性、監管要求、保險報銷、醫生技能以及患者選擇。

臨床證據和設備設計正在重塑市場格局。

該領域的研究重點正從以新穎性為導向的研發轉向基於實證醫學的長期療效評估，包括血管再阻塞、血栓症、血管癒合、長期管腔行為和再次介入治療。設計重點包括支架減薄、可預測的分解、藥物控釋、徑向強度、易於植入和X光顯影。生產一致性和上市後監測仍然至關重要，因為即使聚合物性能、塗層性能或部署特性的細微差異也會影響臨床療效。

人工智慧正在增強開發、選拔和監控能力。

人工智慧 (AI) 可輔助進行臨床前設計最佳化、影像診斷、病灶表徵、手術規劃，並識別可能受益於特定器材策略的患者。機器學習工具還有助於檢測臨床和上市後數據中的訊號，而生成式學習技術可加速材料和塗層研究。有效利用 AI 需要具有代表性的資料集、前瞻性檢驗、可解釋性、網路安全以及明確的臨床決策課責。 AI 應作為醫師判斷的補充，而非替代。

區域洞察：法規、基礎設施和證據驅動普及

在北美，重點在於嚴謹的臨床證據、監管文件、報銷理由以及完善的介入治療基礎設施。在歐洲，先進的循環系統醫療服務與日益嚴格的臨床、安全和上市後要求相結合。在亞太地區，手術方式的多樣性十分突出，其應用受到當地生產能力、醫院採購系統、報銷方案和培訓項目的影響。在拉丁美洲，公立和私立醫療體系的差異、對進口的依賴以及導管介入服務可近性的不均衡都影響著這一現狀。在中東，對三級醫療的投入和專科醫生的集中是推動導管介入應用的主要因素，但採購和報銷方案因市場而異。非洲的情況仍然高度複雜，導管介入能力不足和成本效益低是主要阻礙因素，儘管該地區也在加強轉診網路和提供專科醫生培訓機會。

區域洞察：不同的經濟和監管格局造就了不同的商業環境。

東協市場在監管成熟度、醫院資金籌措和介入性心臟病學服務取得方面存在差異，因此制定區域性客製化的註冊和分銷策略至關重要。金磚國家擁有龐大且多元化的患者群體，而國內生產、報銷和採購環境也因國家而異。歐盟要求遵守區域層級的法規和證據要求，但各國的採購和保險覆蓋範圍仍有很大差異。七國集團（G7）的醫療保健體系通常高度重視臨床價值比較、品管系統和上市後證據。在海灣合作理事會（GCC）國家，先進的心臟病治療往往集中在主要城市和三級醫療機構。北約成員國的醫療保健體系並不完全一致，但許多國家對供應韌性、醫療設備安全性和先進的臨床基礎設施通用很高的期望。

國家概況：各國的證據和進入條件會影響商業性準備。

澳洲和加拿大強調實證採購和地理分散的醫療服務。在巴西和墨西哥，公立和私立醫療體係有顯著差異，報銷機制和進口程序影響著產品的供應。中國和印度在不斷提升介入治療能力的同時，也存在著顯著的區域差異，並且越來越重視本地生產和臨床證據。日本和韓國擁有先進的心血管基礎設施，並制定了詳細的監管要求。在法國、德國、義大利、西班牙和英國，醫療設備的評估途徑因國家和地區而異，醫院採購、醫療技術評估和上市後義務都會影響產品的採用。俄羅斯的商業環境受到法規、供應和醫療服務可近性的影響。在美國，產品的採用取決於監管部門的批准、醫生的信任、保險公司的批准、醫院的經濟狀況以及可靠的長期臨床數據。

生物可吸收冠狀動脈技術領域的領導者應優先考慮的問題

產業領導者應優先進行設計完善、有意義的長期終點指標和透明的亞組分析的比較研究。醫療器材研發專案應從早期設計階段就整合材料科學、塗層控制、影像相容性、遞送性能和生產驗證等要素。監管策略應根據各司法管轄區的具體情況量身定做，並以可追溯的品質系統和積極的上市後監測為支撐。銷售團隊應著重於醫生培訓、基於影像的病例選擇以及建立衛生經濟學證據，而非僅依賴技術差異。與醫院、研究人員和資料專家的合作應有助於臨床應用，而負責任的人工智慧管治必須解決驗證、偏差、隱私和人工監督等問題。

調查方法：基於證據的專業醫療設備市場評估

本執行摘要採用結構化的二次調查框架，重點在於與生物可吸收藥物釋放型冠狀動脈支架系統相關的臨床、技術、監管、醫療服務和報銷因素。該分析需要對同行評審的研究、臨床試驗記錄、監管出版刊物、專業學會指南、採購文件和公開的醫療數據進行多方面的交叉引用。應仔細檢視研究結果的資訊來源品質、發表日期、地理相關性、終點可比性以及潛在的利益衝突。由於醫療設備的性能和使用條件因適應症和司法管轄區而異，結論應區分已確立的證據和新出現的假設，並應隨著長期追蹤結果的公佈而更新。

結論：證據和實施情況決定了永續採用。

生物可吸收藥物釋放型冠狀動脈支架系統旨在實現一項關鍵的臨床目標：在無需永久植入的情況下提供臨時支撐和藥物傳輸。其持續發展更依賴可靠的分解性、易用性、持續的患者療效、可信的對比證據以及一致的監管和生產規範，而非新穎性。那些將工程技術專長與醫生教育、患者篩選、上市後洞察以及區域性准入策略相結合的領導者，將更有能力將這項技術的潛力轉化為負責任的臨床應用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：生物可吸收藥物釋放型冠狀動脈支架系統市場：依產品類型分類

  • 球囊擴張型
  • 自膨脹

第8章：生物可吸收藥物釋放型冠狀動脈支架系統市場：依藥物類型分類

  • 生物黏膜
  • Everolimus
  • Sirolimus

第9章：生物可吸收藥物釋放型冠狀動脈支架系統市場：依聚合物類型分類

  • 聚左旋乳酸
  • 聚己內酯

第10章：生物可吸收藥物釋放型冠狀動脈支架系統市場：依適應症分類

  • 急性冠狀動脈症候群
    • 非ST段抬高型心肌梗塞
    • ST段上升型心肌梗塞
    • 不穩定型心絞痛
  • 穩定性心絞痛

第11章：生物可吸收藥物釋放型冠狀動脈支架系統市場：依最終用戶分類

  • 門診手術中心
  • 心臟醫療中心
  • 醫院

第12章：生物可吸收藥物釋放型冠狀動脈支架系統市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：生物可吸收藥物釋放型冠狀動脈支架系統市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：生物可吸收藥物釋放型冠狀動脈支架系統市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • Amaranth Medical Inc.
  • Arterial Remodeling Technologies SA
  • B. Braun Melsungen AG
  • Biosensors International Group Ltd
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Essen Technology Co. Ltd.
  • Kyoto Medical Planning Co. Ltd.
  • Lepu Medical Technology Co. Ltd.
  • Lifetech Scientific Co. Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • REVA Medical LLC
  • Sahajanand Medical Technologies Private Limited
  • SINOMED
  • Terumo Corporation
  • Translumina Therapeutics LLP
  • Vascular Concepts Limited

第17章 主要專家

Product Code: MRR-EF0BD2D829D5

The Bioabsorbable Eluting Coronary Stent System Market is projected to grow by USD 2.98 billion at a CAGR of 11.58% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.38 billion
Estimated Year [2026] USD 1.54 billion
Forecast Year [2032] USD 2.98 billion
CAGR (%) 11.58%

Bioabsorbable-Eluting Coronary Stent Systems: Executive Overview

Bioabsorbable-eluting coronary stent systems combine temporary mechanical support with controlled drug delivery and subsequent material resorption. Their clinical value proposition is to reduce long-term foreign-body presence while maintaining adequate vessel scaffolding during healing. Adoption is shaped by evidence quality, procedural reliability, regulatory requirements, reimbursement, physician familiarity, and patient selection.

Clinical Evidence and Device Design Are Reshaping the Landscape

The field is shifting from novelty-driven development toward evidence-led assessment of long-term outcomes, including restenosis, thrombosis, vessel healing, late lumen behavior, and repeat intervention. Design priorities include thinner struts, predictable degradation, controlled drug release, radial strength, deliverability, and radiographic visibility. Manufacturing consistency and post-market surveillance remain essential because small changes in polymer behavior, coating performance, or deployment characteristics can affect clinical performance.

Artificial Intelligence Is Strengthening Development, Selection, and Monitoring

Artificial intelligence can support nonclinical design optimization, imaging interpretation, lesion characterization, procedural planning, and identification of patients who may benefit from specific device strategies. Machine-learning tools can also assist with signal detection in clinical and post-market data, while generative methods may accelerate material and coating research. Effective deployment requires representative datasets, prospective validation, explainability, cybersecurity, and clear accountability for clinical decisions; AI should augment rather than replace physician judgment.

Regional Insights: Regulation, Infrastructure, and Evidence Determine Adoption

North America emphasizes rigorous clinical evidence, regulatory documentation, reimbursement justification, and advanced interventional infrastructure. Europe combines sophisticated cardiology services with increasingly demanding clinical, safety, and post-market requirements. Asia-Pacific presents substantial procedural diversity, with adoption influenced by local manufacturing capability, hospital purchasing systems, reimbursement, and training capacity. Latin America is shaped by public-private healthcare differences, import dependence, and uneven access to catheterization services. In the Middle East, tertiary-care investment and specialist concentration support adoption, while procurement and reimbursement vary across markets. Africa remains highly heterogeneous, with limited catheterization capacity and affordability acting as central constraints alongside opportunities to strengthen referral networks and specialist training.

Group Insights: Economic and Regulatory Blocs Create Different Operating Conditions

ASEAN markets differ in regulatory maturity, hospital financing, and access to interventional cardiology, making localized registration and distribution strategies important. BRICS economies combine large and diverse patient populations with varying domestic production, reimbursement, and procurement environments. The European Union requires alignment with regional regulatory and evidence expectations while retaining substantial national variation in purchasing and coverage. G7 systems generally place strong emphasis on comparative clinical value, quality systems, and post-market evidence. GCC countries often concentrate advanced cardiac care in major urban and tertiary institutions. NATO members are not a uniform healthcare bloc, but many share high expectations for supply resilience, device security, and sophisticated clinical infrastructure.

Country Insights: National Evidence and Access Conditions Shape Commercial Readiness

Australia and Canada emphasize evidence-based procurement and geographically dispersed care delivery. Brazil and Mexico face marked variation between private and public systems, with reimbursement and import processes influencing availability. China and India combine expanding interventional capacity with significant regional differences and growing interest in local manufacturing and clinical evidence. Japan and South Korea maintain advanced cardiovascular infrastructure and detailed regulatory expectations. France, Germany, Italy, Spain, and the United Kingdom assess devices through distinct national or regional pathways, with hospital procurement, health technology assessment, and post-market obligations affecting uptake. Russia's operating environment is influenced by regulatory, supply, and healthcare-access conditions. In the United States, adoption depends on regulatory clearance, physician confidence, payer recognition, hospital economics, and robust long-term clinical data.

Actionable Priorities for Leaders in Bioabsorbable Coronary Technologies

Industry leaders should prioritize well-designed comparative studies with meaningful long-term endpoints and transparent subgroup analysis. Device programs should integrate material science, coating control, imaging compatibility, delivery performance, and manufacturing validation from the earliest design stages. Regulatory strategies should be tailored to each jurisdiction, supported by traceable quality systems and active post-market surveillance. Commercial teams should develop physician training, imaging-based case selection, and health-economic evidence rather than relying on technical differentiation alone. Partnerships with hospitals, researchers, and data specialists can improve clinical adoption while responsible AI governance should address validation, bias, privacy, and human oversight.

Research Methodology: Evidence-Led Assessment of a Specialized Device Market

This executive summary uses a structured secondary-research framework focused on the clinical, technical, regulatory, healthcare-delivery, and reimbursement factors relevant to bioabsorbable-eluting coronary stent systems. Analysis should triangulate peer-reviewed studies, clinical-trial records, regulatory publications, professional-society guidance, procurement documentation, and publicly available healthcare data. Findings should be screened for source quality, publication date, geographic relevance, endpoint comparability, and potential conflicts. Because device performance and access conditions vary by indication and jurisdiction, conclusions should distinguish established evidence from emerging hypotheses and should be updated as long-term follow-up becomes available.

Conclusion: Evidence and Execution Will Define Sustainable Adoption

Bioabsorbable-eluting coronary stent systems address an important clinical ambition: providing temporary support and drug delivery without a permanent implant. Their sustainable advancement depends less on novelty than on dependable degradation, procedural usability, durable patient outcomes, credible comparative evidence, and consistent regulatory and manufacturing execution. Leaders that connect engineering discipline with physician education, patient selection, post-market learning, and region-specific access strategies will be better positioned to translate the technology's potential into responsible clinical use.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Bioabsorbable Eluting Coronary Stent System Market, by Product Type

  • 7.1. Introduction
  • 7.2. Balloon Expandable
  • 7.3. Self Expandable

8. Bioabsorbable Eluting Coronary Stent System Market, by Drug Type

  • 8.1. Introduction
  • 8.2. Biolimus
  • 8.3. Everolimus
  • 8.4. Sirolimus

9. Bioabsorbable Eluting Coronary Stent System Market, by Polymer Type

  • 9.1. Introduction
  • 9.2. Poly-L-Lactic Acid
  • 9.3. Polycaprolactone

10. Bioabsorbable Eluting Coronary Stent System Market, by Indication

  • 10.1. Introduction
  • 10.2. Acute Coronary Syndrome
    • 10.2.1. Non-ST Elevation Myocardial Infarction
    • 10.2.2. ST Elevation Myocardial Infarction
    • 10.2.3. Unstable Angina
  • 10.3. Stable Angina

11. Bioabsorbable Eluting Coronary Stent System Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers
  • 11.3. Cardiac Specialty Centers
  • 11.4. Hospitals

12. Bioabsorbable Eluting Coronary Stent System Market, by Region

  • 12.1. Introduction
  • 12.2. Asia-Pacific
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Europe
  • 12.6. Middle East
  • 12.7. Africa

13. Bioabsorbable Eluting Coronary Stent System Market, by Group

  • 13.1. Introduction
  • 13.2. ASEAN
  • 13.3. GCC
  • 13.4. European Union
  • 13.5. BRICS
  • 13.6. G7
  • 13.7. NATO

14. Bioabsorbable Eluting Coronary Stent System Market, by Country

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. United Kingdom
  • 14.7. Germany
  • 14.8. France
  • 14.9. Russia
  • 14.10. Italy
  • 14.11. Spain
  • 14.12. China
  • 14.13. India
  • 14.14. Japan
  • 14.15. Australia
  • 14.16. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. Market Concentration Analysis, 2025
    • 15.2.1. Concentration Ratio (CR)
    • 15.2.2. Herfindahl Hirschman Index (HHI)
  • 15.3. Recent Developments & Impact Analysis, 2025
  • 15.4. Product Portfolio Analysis, 2025
  • 15.5. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. Amaranth Medical Inc.
  • 16.3. Arterial Remodeling Technologies SA
  • 16.4. B. Braun Melsungen AG
  • 16.5. Biosensors International Group Ltd
  • 16.6. BIOTRONIK SE & Co. KG
  • 16.7. Boston Scientific Corporation
  • 16.8. Elixir Medical Corporation
  • 16.9. Essen Technology Co. Ltd.
  • 16.10. Kyoto Medical Planning Co. Ltd.
  • 16.11. Lepu Medical Technology Co. Ltd.
  • 16.12. Lifetech Scientific Co. Ltd.
  • 16.13. Meril Life Sciences Pvt. Ltd.
  • 16.14. MicroPort Scientific Corporation
  • 16.15. REVA Medical LLC
  • 16.16. Sahajanand Medical Technologies Private Limited
  • 16.17. SINOMED
  • 16.18. Terumo Corporation
  • 16.19. Translumina Therapeutics LLP
  • 16.20. Vascular Concepts Limited

17. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Bioabsorbable Eluting Coronary Stent System Market, Years Considered for the Study
  • FIGURE 2. Global Bioabsorbable Eluting Coronary Stent System Market, Research Design
  • FIGURE 3. Global Bioabsorbable Eluting Coronary Stent System Market, Research Framework
  • FIGURE 4. Global Bioabsorbable Eluting Coronary Stent System Market, Data Triangulation
  • FIGURE 5. Global Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2025 vs 2032 (%)
  • FIGURE 9. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2025 vs 2032 (%)
  • FIGURE 11. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2025 vs 2032 (%)
  • FIGURE 13. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 15. Global Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 17. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 20. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Bioabsorbable Eluting Coronary Stent System Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Bioabsorbable Eluting Coronary Stent System Market Segmentation & Coverage
  • TABLE 2. Global Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 4. Global Balloon Expandable Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Balloon Expandable Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Balloon Expandable Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Self Expandable Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Self Expandable Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Self Expandable Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 11. Global Biolimus Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 12. Global Biolimus Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 13. Global Biolimus Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 14. Global Everolimus Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 15. Global Everolimus Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 16. Global Everolimus Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 17. Global Sirolimus Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 18. Global Sirolimus Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 19. Global Sirolimus Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 20. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 21. Global Poly-L-Lactic Acid Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 22. Global Poly-L-Lactic Acid Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 23. Global Poly-L-Lactic Acid Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 24. Global Polycaprolactone Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 25. Global Polycaprolactone Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 26. Global Polycaprolactone Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 27. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 28. Global Acute Coronary Syndrome Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global Acute Coronary Syndrome Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global Acute Coronary Syndrome Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Non-ST Elevation Myocardial Infarction Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 32. Global Non-ST Elevation Myocardial Infarction Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 33. Global Non-ST Elevation Myocardial Infarction Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 34. Global ST Elevation Myocardial Infarction Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 35. Global ST Elevation Myocardial Infarction Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 36. Global ST Elevation Myocardial Infarction Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 37. Global Unstable Angina Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 38. Global Unstable Angina Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 39. Global Unstable Angina Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 40. Global Stable Angina Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 41. Global Stable Angina Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 42. Global Stable Angina Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 43. Global Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 44. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 45. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 46. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 47. Global Cardiac Specialty Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 48. Global Cardiac Specialty Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 49. Global Cardiac Specialty Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 50. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 51. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 52. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 53. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 54. Asia-Pacific Bioabsorbable Eluting Coronary Stent System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 55. Asia-Pacific Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 56. Asia-Pacific Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 57. Asia-Pacific Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 58. Asia-Pacific Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 59. Asia-Pacific Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 60. Asia-Pacific Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 61. North America Bioabsorbable Eluting Coronary Stent System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 62. North America Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 63. North America Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 64. North America Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 65. North America Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 66. North America Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 67. North America Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 68. Latin America Bioabsorbable Eluting Coronary Stent System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 69. Latin America Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 70. Latin America Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 71. Latin America Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 72. Latin America Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 73. Latin America Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 74. Latin America Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 75. Europe Bioabsorbable Eluting Coronary Stent System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 76. Europe Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 77. Europe Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 78. Europe Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 79. Europe Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 80. Europe Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 81. Europe Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 82. Middle East Bioabsorbable Eluting Coronary Stent System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 83. Middle East Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 84. Middle East Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 85. Middle East Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 86. Middle East Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 87. Middle East Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 88. Middle East Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 89. Africa Bioabsorbable Eluting Coronary Stent System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 90. Africa Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 91. Africa Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 92. Africa Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 93. Africa Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 94. Africa Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 95. Africa Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 96. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 97. ASEAN Bioabsorbable Eluting Coronary Stent System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 98. ASEAN Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 99. ASEAN Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 100. ASEAN Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 101. ASEAN Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 102. ASEAN Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 103. ASEAN Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 104. GCC Bioabsorbable Eluting Coronary Stent System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 105. GCC Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 106. GCC Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 107. GCC Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 108. GCC Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 109. GCC Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 110. GCC Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 111. European Union Bioabsorbable Eluting Coronary Stent System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 112. European Union Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 113. European Union Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 114. European Union Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 115. European Union Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 116. European Union Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 117. European Union Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 118. BRICS Bioabsorbable Eluting Coronary Stent System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 119. BRICS Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 120. BRICS Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 121. BRICS Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 122. BRICS Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 123. BRICS Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 124. BRICS Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 125. G7 Bioabsorbable Eluting Coronary Stent System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 126. G7 Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 127. G7 Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 128. G7 Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 129. G7 Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 130. G7 Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 131. G7 Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 132. NATO Bioabsorbable Eluting Coronary Stent System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 133. NATO Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 134. NATO Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 135. NATO Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 136. NATO Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 137. NATO Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 138. NATO Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 139. Global Bioabsorbable Eluting Coronary Stent System Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 140. United States Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
  • TABLE 141. United States Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 142. United States Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 143. United States Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 144. United States Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 145. United States Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 146. United States Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 147. Canada Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
  • TABLE 148. Canada Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 149. Canada Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 150. Canada Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 151. Canada Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 152. Canada Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 153. Canada Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 154. Mexico Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
  • TABLE 155. Mexico Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 156. Mexico Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 157. Mexico Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 158. Mexico Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 159. Mexico Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 160. Mexico Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 161. Brazil Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
  • TABLE 162. Brazil Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 163. Brazil Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 164. Brazil Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 165. Brazil Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 166. Brazil Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 167. Brazil Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 168. United Kingdom Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
  • TABLE 169. United Kingdom Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 170. United Kingdom Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 171. United Kingdom Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 172. United Kingdom Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 173. United Kingdom Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 174. United Kingdom Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 175. Germany Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
  • TABLE 176. Germany Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 177. Germany Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 178. Germany Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 179. Germany Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 180. Germany Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 181. Germany Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 182. France Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
  • TABLE 183. France Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 184. France Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 185. France Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 186. France Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 187. France Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 188. France Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 189. Russia Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
  • TABLE 190. Russia Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 191. Russia Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 192. Russia Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 193. Russia Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 194. Russia Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 195. Russia Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 196. Italy Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
  • TABLE 197. Italy Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 198. Italy Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 199. Italy Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 200. Italy Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 201. Italy Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 202. Italy Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 203. Spain Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
  • TABLE 204. Spain Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 205. Spain Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 206. Spain Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 207. Spain Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 208. Spain Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 209. Spain Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 210. China Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
  • TABLE 211. China Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 212. China Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 213. China Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 214. China Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 215. China Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 216. China Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 217. India Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
  • TABLE 218. India Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 219. India Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 220. India Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 221. India Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 222. India Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 223. India Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 224. Japan Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
  • TABLE 225. Japan Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 226. Japan Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 227. Japan Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 228. Japan Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 229. Japan Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 230. Japan Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 231. Australia Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
  • TABLE 232. Australia Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 233. Australia Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 234. Australia Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 235. Australia Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 236. Australia Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 237. Australia Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 238. South Korea Bioabsorbable Eluting Coronary Stent System Market Size, 2017-2032 (USD Million)
  • TABLE 239. South Korea Bioabsorbable Eluting Coronary Stent System Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 240. South Korea Bioabsorbable Eluting Coronary Stent System Market Size, by Drug Type, 2017-2032 (USD Million)
  • TABLE 241. South Korea Bioabsorbable Eluting Coronary Stent System Market Size, by Polymer Type, 2017-2032 (USD Million)
  • TABLE 242. South Korea Bioabsorbable Eluting Coronary Stent System Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 243. South Korea Bioabsorbable Eluting Coronary Stent System Market Size, by Acute Coronary Syndrome, 2017-2032 (USD Million)
  • TABLE 244. South Korea Bioabsorbable Eluting Coronary Stent System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 245. Global Bioabsorbable Eluting Coronary Stent System Market Share, by Key Player, 2025
  • TABLE 246. Global Bioabsorbable Eluting Coronary Stent System Market, Key Experts